175 related articles for article (PubMed ID: 27694828)
1. Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.
Kim JA; Tan Y; Wang X; Cao X; Veeraraghavan J; Liang Y; Edwards DP; Huang S; Pan X; Li K; Schiff R; Wang XS
Nat Commun; 2016 Oct; 7():12991. PubMed ID: 27694828
[TBL] [Abstract][Full Text] [Related]
2. Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint.
Kim JA; Anurag M; Veeraraghavan J; Schiff R; Li K; Wang XS
Mol Cancer Res; 2016 Oct; 14(10):920-927. PubMed ID: 27489360
[TBL] [Abstract][Full Text] [Related]
3. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers.
Veeraraghavan J; Tan Y; Cao XX; Kim JA; Wang X; Chamness GC; Maiti SN; Cooper LJ; Edwards DP; Contreras A; Hilsenbeck SG; Chang EC; Schiff R; Wang XS
Nat Commun; 2014 Aug; 5():4577. PubMed ID: 25099679
[TBL] [Abstract][Full Text] [Related]
4. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
5. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
[TBL] [Abstract][Full Text] [Related]
6. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.
Yu L; Liang Y; Cao X; Wang X; Gao H; Lin SY; Schiff R; Wang XS; Li K
Oncogene; 2017 May; 36(20):2910-2918. PubMed ID: 27893709
[TBL] [Abstract][Full Text] [Related]
7. TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.
Lin M; Yao Z; Zhao N; Zhang C
Cancer Biol Ther; 2019; 20(1):101-108. PubMed ID: 30207834
[TBL] [Abstract][Full Text] [Related]
8. High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.
Bennett L; Quinn J; McCall P; Mallon EA; Horgan PG; McMillan DC; Paul A; Edwards J
Int J Cancer; 2017 Apr; 140(7):1633-1644. PubMed ID: 28006839
[TBL] [Abstract][Full Text] [Related]
9. MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer.
Park J; Kim GH; Lee J; Phuong BTC; Kong B; Won JE; Won GW; Lee YH; Han HD; Lee Y
Toxicol Appl Pharmacol; 2020 Dec; 408():115257. PubMed ID: 33007383
[TBL] [Abstract][Full Text] [Related]
10. Differential requirements for Tousled-like kinases 1 and 2 in mammalian development.
Segura-Bayona S; Knobel PA; González-Burón H; Youssef SA; Peña-Blanco A; Coyaud É; López-Rovira T; Rein K; Palenzuela L; Colombelli J; Forrow S; Raught B; Groth A; de Bruin A; Stracker TH
Cell Death Differ; 2017 Nov; 24(11):1872-1885. PubMed ID: 28708136
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomics connects somatic mutations to signalling in breast cancer.
Mertins P; Mani DR; Ruggles KV; Gillette MA; Clauser KR; Wang P; Wang X; Qiao JW; Cao S; Petralia F; Kawaler E; Mundt F; Krug K; Tu Z; Lei JT; Gatza ML; Wilkerson M; Perou CM; Yellapantula V; Huang KL; Lin C; McLellan MD; Yan P; Davies SR; Townsend RR; Skates SJ; Wang J; Zhang B; Kinsinger CR; Mesri M; Rodriguez H; Ding L; Paulovich AG; Fenyö D; Ellis MJ; Carr SA;
Nature; 2016 Jun; 534(7605):55-62. PubMed ID: 27251275
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
15. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
16. Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.
Yang KM; Jung Y; Lee JM; Kim W; Cho JK; Jeong J; Kim SJ
Cancer Res; 2013 Nov; 73(22):6679-89. PubMed ID: 24062311
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
18. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.
Fagan-Solis KD; Pentecost BT; Gozgit JM; Bentley BA; Marconi SM; Otis CN; Anderton DL; Schneider SS; Arcaro KF
J Cell Physiol; 2014 Sep; 229(9):1160-9. PubMed ID: 24443386
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.
West NR; Murphy LC; Watson PH
Endocr Relat Cancer; 2012 Apr; 19(2):181-95. PubMed ID: 22267707
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
